- Home
- JNVR vs BFRI Comparison
JNVR vs BFRI Comparison
Compare JNVR & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- BFRI
- Stock Information
- Founded
- JNVR 2018
- BFRI 1997
- Country
- JNVR United States
- BFRI United States
- Employees
- JNVR N/A
- BFRI N/A
- Industry
- JNVR Finance: Consumer Services
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- JNVR Finance
- BFRI Health Care
- Exchange
- JNVR Nasdaq
- BFRI Nasdaq
- Market Cap
- JNVR 5.1M
- BFRI 6.2M
- IPO Year
- JNVR 2023
- BFRI 2021
- Fundamental
- Price
- JNVR $0.49
- BFRI $0.76
- Analyst Decision
- JNVR
- BFRI Strong Buy
- Analyst Count
- JNVR 0
- BFRI 1
- Target Price
- JNVR N/A
- BFRI $7.00
- AVG Volume (30 Days)
- JNVR 1.2M
- BFRI 7.3M
- Earning Date
- JNVR 11-06-2024
- BFRI 11-13-2024
- Dividend Yield
- JNVR N/A
- BFRI N/A
- EPS Growth
- JNVR N/A
- BFRI N/A
- EPS
- JNVR N/A
- BFRI N/A
- Revenue
- JNVR $1,820,969.00
- BFRI $35,358,000.00
- Revenue This Year
- JNVR N/A
- BFRI $19.11
- Revenue Next Year
- JNVR N/A
- BFRI $20.16
- P/E Ratio
- JNVR N/A
- BFRI N/A
- Revenue Growth
- JNVR N/A
- BFRI 5.17
- 52 Week Low
- JNVR $0.42
- BFRI $0.61
- 52 Week High
- JNVR $1.84
- BFRI $4.04
- Technical
- Relative Strength Index (RSI)
- JNVR 39.92
- BFRI 43.25
- Support Level
- JNVR $0.43
- BFRI $0.65
- Resistance Level
- JNVR $0.69
- BFRI $0.79
- Average True Range (ATR)
- JNVR 0.09
- BFRI 0.11
- MACD
- JNVR -0.01
- BFRI -0.01
- Stochastic Oscillator
- JNVR 16.78
- BFRI 26.41
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.